Data workstation Eveo

for laboratoryfor clean roomsfor medical applications

Overview
Sartorius Eveo Cell Therapy Platform is a closed, user-owned, modular, multi-parallel intensified processing platform designed for multiple cell therapy product types across centralized and decentralized manufacturing models. The platform combines smart automation, quality control, and engineered raw materials to enable GMP production with focus on process ownership, usability and commercial-scale readiness.

Key Benefits & Metrics

• Parallel Processing: run up to 8 concurrent, unique batches in each Eveo Cell Therapy Workstation.
• Throughput: achieve more than 350 doses per year using a single workstation and a single operator, within a 6 m² footprint.
• Productivity: up to 4x more productivity per unit floor space versus conventional manufacturing methods.
• Operational efficiency and cost: reported ~80% CAPEX reduction and significant operational efficiency improvements; built-in cost reduction with reported COGS per batch under $35k and up to ~90% cost reduction compared to traditional processes.

Process Design & Compliance

• Closed, guided, automated operation engineered to minimize batch-failure rates via online visual guidance and automated liquid path connection, verification and disconnection.
• Operates across cleanroom classifications from Grade C / D (ISO 7 / 8) environments or in controlled non-classified spaces because of its fully closed design.
• Compatible with whole blood–based protocols and perfusion-enabled cell culture to reduce total processing times and dependence on limited apheresis appointments.

Performance & Technology

• High transduction efficiency: reported >70% transduction efficiency without need for transduction enhancers for some workflows.
• Perfusion-based, variable-volume bioreactor culture with inline analytics to accelerate timelines and reach dose days faster than established techniques.
• Multi-parallel Eveo Bioreactor Stations enable processing of up to 8 batches in parallel (separated in time and space) to scale output per workstation.
• Eveo Weld, Verify, Seal: fully automated connection/disconnection and liquid path verification to reduce error rates and lower facility cleanroom requirements relative to some legacy approaches.
• Eveo Smart Guidance: human-centric visual support and full component tracking to reduce operator error and streamline compliance and documentation workflows.

Raw Materials & Consumables

• High-performance raw materials supplied in pre-filled bags engineered for the Eveo Workstation to ensure seamless installation and workflow efficiency.

Claims & Supporting Figures

• Run 8 batches in 6 square metres with a single workstation.
• ~20% reduction in vein-to-vein time through compatibility with whole blood protocols and perfusion-enabled culture.

Characteristics / Technical specifications

• Platform name: Eveo Cell Therapy Platform
• Manufacturer / Brand: Sartorius
• System architecture: closed, modular, multi-parallel intensified processing platform
• Parallel batches per workstation: up to 8 concurrent, unique batches
• Annual throughput (example): >350 doses per year (single workstation, single operator)
• Footprint: example metrics indicate 6 m² for a single workstation configuration
• Productivity: up to 4x productivity per unit floor space vs conventional methods
• CAPEX reduction: reported ~80% reduction (customer-reported metric)
• COGS per batch: reported < $35,000 (example metric)
• Cleanroom compatibility: designed to operate in Grade C / D (ISO 7 / 8) or controlled non-classified spaces
• Culture method: perfusion-based, variable-volume bioreactor with inline analytics
• Transduction efficiency: reported >70% for some CAR-T workflows
• Automation features: automated liquid path connection/verification/disconnection; guided visual support; full component tracking
• Consumables: pre-filled, Eveo-engineered raw material bags and compatible single-use components